Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Won Kim

Showing results (331-340 of 634) with videos related to

Pageof 64
Sort By:
Annals of Surgical Oncology|November 27, 2009
Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancerSun Jin Sym, Heung Moon Chang, Min-Hee Ryu, et al.
Cancer Research and Treatment|December 4, 2009
Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapyJae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, et al.
Annals of Coloproctology|July 21, 2016
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver MetastasesKi Ung Jang, Chan Wook Kim, Ki-Hun Kim, et al.
Clinics in Orthopedic Surgery|September 13, 2011
Characteristics and trends of orthopedic publications between 2000 and 2009Kyoung Min Lee, Mi Sun Ryu, Chin Youb Chung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 14, 2011
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patientsDong Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
Soa--Ch'Ongsonyon Chongsin Uihak = Journal of Child & Adolescent Psychiatry|June 30, 2020
Effect of School-Based Social Skills Training Program on Peer Relationships: Preliminary StudyHong-Shik Roh, Jung-Uk Shin, Jae-Woo Lee, et al.
Clinical Colorectal Cancer|July 20, 2024
Effects of Adjuvant Chemotherapy on Oncologic Outcomes in Patients With Stage ⅡA Rectal Cancer Above the Peritoneal Reflection Who Did Not Undergo Preoperative ChemoradiotherapyHyo Seon Ryu, Jong Lyul Lee, Chan Wook Kim, et al.
Investigational New Drugs|November 25, 2010
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patientsDok Hyun Yoon, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Clinical Colorectal Cancer|January 2, 2019
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best PracticeTanios Bekaii-Saab, Richard Kim, Tae Won Kim, et al.
Pageof 64

Showing results (331-340 of 634) with videos related to

Sort By:
Pageof 64
Annals of Surgical Oncology|November 27, 2009
Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancerSun Jin Sym, Heung Moon Chang, Min-Hee Ryu, et al.
Cancer Research and Treatment|December 4, 2009
Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapyJae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, et al.
Annals of Coloproctology|July 21, 2016
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver MetastasesKi Ung Jang, Chan Wook Kim, Ki-Hun Kim, et al.
Clinics in Orthopedic Surgery|September 13, 2011
Characteristics and trends of orthopedic publications between 2000 and 2009Kyoung Min Lee, Mi Sun Ryu, Chin Youb Chung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 14, 2011
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patientsDong Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
Soa--Ch'Ongsonyon Chongsin Uihak = Journal of Child & Adolescent Psychiatry|June 30, 2020
Effect of School-Based Social Skills Training Program on Peer Relationships: Preliminary StudyHong-Shik Roh, Jung-Uk Shin, Jae-Woo Lee, et al.
Clinical Colorectal Cancer|July 20, 2024
Effects of Adjuvant Chemotherapy on Oncologic Outcomes in Patients With Stage ⅡA Rectal Cancer Above the Peritoneal Reflection Who Did Not Undergo Preoperative ChemoradiotherapyHyo Seon Ryu, Jong Lyul Lee, Chan Wook Kim, et al.
Investigational New Drugs|November 25, 2010
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patientsDok Hyun Yoon, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Clinical Colorectal Cancer|January 2, 2019
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best PracticeTanios Bekaii-Saab, Richard Kim, Tae Won Kim, et al.
Pageof 64